Benign Prostatic Hyperplasia, Bladder Cancer, Kidney Cancer, Kidney Stones, Prostate Cancer, Testicular Cancer, Urology
Dr. Stephen M. Schatz is an assistant professor of urology at the Johns Hopkins School of Medicine. He has specific interests in benign prostate hyperplasia (BPH), kidney stone treatment and prevention, and urologic oncology—cancers of the urinary tract, including bladder, kidney, bladder, prostate, and testis.
Dr. Schatz received his A.B. in premed/history from Columbia College of Columbia University in the City of New York. He went on to study at the University of Pittsburgh School of Medicine, where he was elected to the Alpha Omega Alpha medical honor society. He completed his internship in surgery and residency in urology at Mayo Clinic in Rochester, Minnesota, where he was recognized as the 2005 Outstanding Laparoendoscopic Resident Surgeon by the Society of Laparoendoscopic Surgeons. Dr. Schatz joined the Johns Hopkins faculty in 2009.
Dr. Schatz's research is focused on developing new treatments for men with BPH. He is currently serving as co-investigator on a clinical trial exploring the use of prostatic artery embolization in men suffering from symptoms related to BPH. He has conducted research in the past on treatment effects from permanent prostate brachytherapy and the physiology of laparoscopic surgery.
Dr. Schatz lectures locally and nationally to urologists, primary care physicians, and medical students on the natural history and treatment of BPH.